Time-course experiments indicated that kynurenine release from IFN-γ-activated AML blasts progressively increased over time, reaching maximum levels 48-72 hours after the addition of IFN-γ to the cultures (Figure 1D). This evidence concerns the gene IFNG and acute myeloid leukemia.